News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Tennessee
Mergers & acquisitions
Crown Laboratories to Buy Botox Rival Revance Therapeutics for $924M
The acquisition announced Monday will give Crown access to Revance’s Daxxify, a competitor to AbbVie’s Botox, which is indicated for frown lines and for cervical dystonia.
August 13, 2024
·
2 min read
·
Tristan Manalac
PRESS RELEASES
Press Releases
Daxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025
February 20, 2025
·
4 min read
Press Releases
Daxor to Exhibit at World’s Largest Critical Care Conference
February 19, 2025
·
3 min read
Press Releases
Surgery Partners, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call Details
February 18, 2025
·
1 min read
Press Releases
New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care
February 14, 2025
·
3 min read
Press Releases
Aegis Sciences Corporation Launches Innovative Dashboard to Track Novel Psychoactive Substances Nationwide
February 11, 2025
·
2 min read
Press Releases
Resource Label Group Expands into Quebec with the Acquisition of Imprimerie Ste-Julie
February 10, 2025
·
2 min read
Press Releases
2025 Product of the Year USA Awarded to PBZ OTC Pyribenzamine Antihistamine Cream
February 7, 2025
·
3 min read
Press Releases
Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics
February 6, 2025
·
4 min read
Press Releases
VION Biosciences Acquires Enzymatic Assay Innovator BioAssay Systems
February 5, 2025
·
2 min read
Press Releases
Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer
February 5, 2025
·
5 min read
Press Releases
Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline
January 31, 2025
·
9 min read
Press Releases
Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital
January 28, 2025
·
2 min read
Press Releases
Petauri Welcomes Mark Levonyak as Executive Vice President, New Business
January 23, 2025
·
2 min read
Press Releases
Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer
January 21, 2025
·
10 min read
Press Releases
Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN
January 21, 2025
·
4 min read
Press Releases
Neuraly and Enigma Biomedical USA announce a Research License and Commercialization Option Agreement for PET Imaging Biomarker, PMI04
January 17, 2025
·
4 min read
Press Releases
Enigma Biomedical USA and the University of Wisconsin–Madison announce Formation of a Partnership to Advance Development of Next-Generation Imaging and Fluid Biomarkers for Improved Understanding and Management of Neurodegenerative Diseases
January 16, 2025
·
3 min read
Press Releases
Veteran Clinical Research Executive Steve Clemons Joins ObjectiveHealth as CEO
January 16, 2025
·
3 min read
Press Releases
Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus’s Spinoff Company for Rose Bengal-Based Eye Drugs
January 15, 2025
·
5 min read
Press Releases
VisiRose Announces $3 Million Seed Financing Round to Advance Ocular Therapeutics
January 15, 2025
·
2 min read
